Trials / Recruiting
RecruitingNCT05036629
Development of MRI Protocols and Associated Neuro-physiological Explorations in Healthy and Pathological Subjects
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
IRMaGe is a Joint Service Unit (UMS) which provides users of brain exploration equipment (clinical MRI and preclinical, TMS, EEG, NIRS and metabolomics). The methods available on this equipment are intended to evolve according to the most recent discoveries and this protocol aims to frame the developments necessary around clinical MRI for IRMaGe can continue to offer tools at the cutting edge of technology.
Detailed description
The studies will be carried out on healthy subjects and voluntary patients, who will have given their consent. Their main objective will be the development and optimization of sequence parameters or design stimulation paradigms in order to optimize the quality and relevance of the images produced taking into account the parameters anatomical, functional or metabolic while respecting the experimental constraints imposed by the protocol concerned (equipment of experimentation, additional physiological measurements, etc.). The main judgement criteria will be measurements inherent in the MRI sequence and a physiological measurement associated in the protocol concerned
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MRI Protocol | Eye-tracker Eyelink (eye movements) BIOPAC : (electrodermal resistance) INVIVO Precess : breathing, arterial pressure, pulse, * NIRS Oxymon artinis medical system * tES (transcranial electrical stimulation, Neuroelectrics) |
Timeline
- Start date
- 2021-09-09
- Primary completion
- 2026-09-08
- Completion
- 2026-09-08
- First posted
- 2021-09-05
- Last updated
- 2023-10-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05036629. Inclusion in this directory is not an endorsement.